OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study

Post-approval observational study of subjects that were enrolled and transplanted in the OCS Liver PROTECT CAP.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Liver Transplant

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Scripps, La Jolla, California, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subjects transplanted in the OCS Liver PROTECT CAP

Treatment and study plan

OCS Liver

Device

Transplant with an OCS preserved liver.

Primary outcomes

Graft Survival

Time frame: 24 Months

Liver Graft Survival at 24 months post-transplant.

Sponsors and collaborators

Lead sponsor

TransMedics

Industry

Registry information

Important dates

Study start: 2020
Primary completion: 2023
Study completion: 2023
First posted: Oct 27, 2021
Registry last updated: Dec 8, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed